Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy

Area of Science:

• Nephrology
• Vascular Biology
• Endocrinology

Background:

• Diabetic nephropathy pathogenesis is poorly understood, lacking adequate animal models.
• Endothelial dysfunction in diabetes may uncouple the vascular endothelial growth factor (VEGF)-endothelial nitric oxide (eNO) axis.
• This uncoupling is hypothesized to contribute significantly to diabetic vasculopathy.

Purpose of the Study:

• To test the hypothesis that VEGF-NO uncoupling is a major mechanism in diabetic nephropathy.
• To investigate the role of endothelial nitric oxide synthase (eNOS) deficiency in diabetic kidney disease development.
• To evaluate the therapeutic potential of insulin in a relevant animal model.

Main Methods:

• Diabetes was induced in eNOS knockout (KO) mice and C57BL6 controls.
• Diabetic eNOS KO mice were assessed for hypertension, albuminuria, renal insufficiency, and specific histological changes.
• Functional and histological outcomes were compared between diabetic and non-diabetic groups, with and without insulin therapy.

Main Results:

• Diabetic eNOS KO mice exhibited hypertension, albuminuria, renal insufficiency, and characteristic diabetic nephropathy lesions (e.g., Kimmelstiel-Wilson nodules).
• Increased glomerular and peritubular capillaries with endothelial proliferation and VEGF expression were observed.
• Insulin therapy significantly improved the observed functional and histological abnormalities, reducing mortality.

Conclusions:

• Inhibition of eNO predisposes mice to classic diabetic nephropathy, likely via VEGF-NO uncoupling and endothelial cell proliferation.
• The findings suggest that endothelial dysfunction, particularly concerning eNO, is a critical factor in diabetic nephropathy development.
• Correction of endothelial dysfunction may represent a therapeutic strategy to prevent or treat diabetic kidney complications.